If BAF155 and BAF170 indeed modulate cellular bioenergetics in a variety of eukaryotic cells, their dysfunction may underlie the pathogenesis of a wide range of common diseases, including cancer, neurological diseases and diabetes. Here, SMARCC1 is linked to cancer.